| Trial ID: | L0650 |
| Source ID: | NCT00958451
|
| Associated Drug: |
Paricalcitol
|
| Title: |
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Secondary Hyperparathyroidism|Chronic Kidney Disease
|
| Interventions: |
DRUG: Paricalcitol|DRUG: Ergocalciferol
|
| Outcome Measures: |
Primary: To achieve 2 consecutive iPTH measurements with 30% or greater decrease from baseline, 2 years | Secondary: To achieve 25OHD level above 30 ng/ml and change cardiovascular markers, 2 years
|
| Sponsor/Collaborators: |
Sponsor: Salem Veterans Affairs Medical Center | Collaborators: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-07
|
| Completion Date: |
2011-01
|
| Results First Posted: |
|
| Last Update Posted: |
2011-03-24
|
| Locations: |
VA Medical Center, Salem, Virginia, 24153, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00958451
|
